Cargando…
Structural Diversity and Initial Oligomerization of PrP106–126 Studied by Replica-Exchange and Conventional Molecular Dynamics Simulations
Prion diseases are marked by cerebral accumulation of the abnormal isoform of the prion protein. A fragment of prion protein composed of residues 106–126 (PrP106–126) exhibits similar properties to full length prion and plays a key role in the conformational conversion from cellular prion to its pat...
Autores principales: | Ning, Lulu, Guo, Jingjing, Bai, Qifeng, Jin, Nengzhi, Liu, Huanxiang, Yao, Xiaojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929351/ https://www.ncbi.nlm.nih.gov/pubmed/24586266 http://dx.doi.org/10.1371/journal.pone.0087266 |
Ejemplares similares
-
Effects of the Pathogenic Mutation A117V and the Protective Mutation H111S on the Folding and Aggregation of PrP106-126: Insights from Replica Exchange Molecular Dynamics Simulations
por: Ning, Lulu, et al.
Publicado: (2015) -
CD36 Participates in PrP(106–126)-Induced Activation of Microglia
por: Kouadir, Mohammed, et al.
Publicado: (2012) -
Correction: CD36 Participates in PrP(106–126)-Induced Activation of Microglia
por: Kouadir, Mohammed, et al.
Publicado: (2012) -
Cardiolipin externalization mediates prion protein (PrP) peptide 106–126-associated mitophagy and mitochondrial dysfunction
por: Yang, Dongming, et al.
Publicado: (2023) -
PHB2 Alleviates Neurotoxicity of Prion Peptide PrP(106–126) via PINK1/Parkin-Dependent Mitophagy
por: Zheng, Xiaohui, et al.
Publicado: (2023)